tiprankstipranks
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
Want to see DMAC full AI Analyst Report?

Compare Diamedica Therapeutics (DMAC) vs. Competitors

572 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Diamedica Therapeutics
$6.85
$340.54M
-9.07
71.27%
3 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.39
$39.21M
-1.38
-83.95%
3 Buy
2 Hold
1 Sell
Moderate Buy
Capricor Therapeutics
$34.70
$1.76B
-11.68
335.87%
8 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.91
$396.37M
-2.11
-48.44%
7 Buy
4 Hold
2 Sell
Moderate Buy
Benitec Biopharma
$14.08
$421.87M
-13.08
-10.63%
2 Buy
0 Hold
0 Sell
Moderate Buy
Annexon Biosciences
$6.54
$924.67M
-6.09
234.71%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMAC
Diamedica Therapeutics
6.32
2.66
72.68%
TVRD
Tvardi Therapeutics
4.18
-21.43
-83.68%
CAPR
Capricor Therapeutics
30.38
24.04
379.18%
RCKT
Rocket Pharmaceuticals
3.63
-3.36
-48.07%
BNTC
Benitec Biopharma
12.28
-1.35
-9.90%
ANNX
Annexon Biosciences
5.69
4.09
255.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts